Comprehensive analysis of serum peptides as candidate biomarkers for inflammatory bowel diseases

Comprehensive analysis of serum peptides useful for diagnosis of inflammatory bowel diseases - Analysis of serum peptides useful for diagnosis of IBD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037592

Enrollment

700

Registered

2019-09-01

Start date

2018-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis, Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed and suspected as ulcerative colitis, Crohn's disease, intestinal Behcet's disease, rheumatoid arthritis, and collagen diseases in St. Marianna University Hospital. Healthy individuals who visited St. Marianna University Hospital and who are staff members of St. Marianna University School of Medicine and St. Marianna University Hospital.

Exclusion criteria

Exclusion criteria: Patients whose condition is not good, i.e., moderate to severe anemia

Design outcomes

Primary

Measure	Time frame
Ion intensity of serum peptides and usefulness of discriminant models for inflammatory bowel diseases generated by the serum peptide ion intensity	—

Secondary

Measure	Time frame
Protein spot intensity obtained from 2-dimensional electrophoresis of peripheral blood mononuclear cell-derived proteins	—

Countries

Japan

Contacts

Public ContactMasaki Kato

St. Marianna University School of Medicine Division of Gastroenterology, Department of Internal Medicine

masaki0801_3@marianna-u.ac.jp81-44-977-8111

Outcome results